Search

Graphical abstractDisplay Omitted HighlightsNovel cost-sensitive hybrid ensemble for efficient breast thermogram classification.Evolutionary algorithm for simultaneous feature selection and classifier weighting.A combined criterion for the ensemble training algorithm.Estimating cost parameter with the usage of ROC analysis.Embedded pruning procedure for discarding irrelevant classifiers. ObjectivesEarly recognition of breast cancer, the most commonly diagnosed form of cancer in women, is of crucial importance, given that it leads to significantly improved chances of survival. Medical thermography, which uses an infrared camera for thermal imaging, has been demonstrated as a particularly useful technique for early diagnosis, because it detects smaller tumors than the standard modality of mammography. Methods and materialIn this paper, we analyse breast thermograms by extracting features describing bilateral symmetries between the two breast areas, and present a classification system for decision making. Clearly, the costs associated with missing a cancer case are much higher than those for mislabelling a benign case. At the same time, datasets contain significantly fewer malignant cases than benign ones. Standard classification approaches fail to consider either of these aspects. In this paper, we introduce a hybrid cost-sensitive classifier ensemble to address this challenging problem. Our approach entails a pool of cost-sensitive decision trees which assign a higher misclassification cost to the malignant class, thereby boosting its recognition rate. A genetic algorithm is employed for simultaneous feature selection and classifier fusion. As an optimisation criterion, we use a combination of misclassification cost and diversity to achieve both a high sensitivity and a heterogeneous ensemble. Furthermore, we prune our ensemble by discarding classifiers that contribute minimally to the decision making. ResultsFor a challenging dataset of about 150 thermograms, our approach achieves an excellent sensitivity of 83.10%, while maintaining a high specificity of 89.44%. This not only signifies improved recognition of malignant cases, it also statistically outperforms other state-of-the-art algorithms designed for imbalanced classification, and hence provides an effective approach for analysing breast thermograms. ConclusionsOur proposed hybrid cost-sensitive ensemble can facilitate a highly accurate early diagnostic of breast cancer based on thermogram features. It overcomes the difficulties posed by the imbalanced distribution of patients in the two analysed groups.

Objective: Accurate cancer prognosis prediction is critical to cancer treatment. There have been many prognosis models based on clinical markers, but few of them are satisfied in clinical applications. And with the development of microarray technologies, cancer researchers have discovered many genes as new markers from the gene expression data and have further developed powerful prognosis models based on these so-called genetic biomarkers. However, the application of such biomarkers still suffers from some problems. The first one is there are a great number of genes and a few samples in the gene expression data so that it is difficult to select a unified gene set to establish a stable classifier for prognosis. The second one is that, due to the experimental and technical reasons, there are existing noises and redundancies in gene expression data, which may lead to building a prognosis predictor with poor performance. The last but not the least one is the microarray experiments are so expensive currently that it is hard to obtain abundant samples. Therefore, it is practical to develop prognosis methods mainly based on conventional clinical markers in real cancer treatment applications. This paper aims to establish an accurate classification model for cancer prognosis, in order to make full use of the invaluable information in clinical data, especially which is usually ignored by most of the existing methods when they aim for high prediction accuracies. Methods: First, this paper gives the formal description of general classification problem, and presents a novel mixture classification model to make full use of the invaluable information in clinical data, which is similar to the traditional ensemble classification models except for putting strict constraints on the construction of mapping functions to avoid voting process. Then, a two-layer instance of the proposed model, named as MRS (Mixture of Rough set and Support vector machine), is constructed by integrating rough set and support vector machine (SVM) classification methods, in which, the rough set classifier acts as the first layer to identify some singular samples in data, and the SVM classifier acts as the second layer to classify the remaining samples. Finally, MRS is used to make prognosis prediction on two open breast cancer datasets. One dataset, denoted as BRC-1 hereafter, is a high quality, publicly available dataset of 97 breast cancer tumors of node-negative patients. The other, denoted as BRC-2 hereafter, uses baseline human primary breast tumor data from LBL breast cancer cell collection containing 174 samples. Results: We have done two experiments on BRC-1 and BRC-2, respectively. In the first experiment, the BRC-1 dataset is divided into train set with 78 patients (34 ones belonging to poor prognosis group and 44 ones belonging to good prognosis group) and test set with 19 patients (12 ones belonging to poor prognosis group and 7 ones belonging to good prognosis). After trained on the train set, the MRS can correctly classify all the 12 patients with poor prognosis, and 6 of 7 patients with good prognosis in the test set. The results are better than previous researches, even better than the 70-gene based biomarkers. And in the second experiment, we construct the classifiers using BRC-2 dataset, and compare MRS with other representative methods in Weka software by 5-fold cross-validation, and comparison results show that MRS has higher prediction accuracy than those methods. Conclusions: The proposed mixture classification model can easily integrate methods with different characteristics. It can overcome the shortcomings of traditional voting-based ensemble models and thus can make full use of the information in clinical data. The experimental results illustrate that our implemented MRS classifier can predict the breast cancer prognosis more accurately than previous prognostic methods.

International audience; Nowadays, breast and cervical cancers are respectively the first and fourth most common causes of cancer death in females. It is believed that, automated systems based on artificial intelligence would allow the early diagnostic which increases significantly the chances of proper treatment and survival. Although Convolutional Neural Networks (CNNs) have achieved human-level performance in object classification tasks, the regular growing of the amount of medical data and the continuous increase of the number of classes make them difficult to learn new tasks without being re-trained from scratch. Nevertheless, fine tuning and transfer learning in deep models are techniques that lead to the well-known catastrophic forgetting problem. In this paper, an Incremental Deep Tree (IDT) framework for biological image classification is proposed to address the catastrophic forgetting of CNNs allowing them to learn new classes while maintaining acceptable accuracies on the previously learnt ones. To evaluate the performance of our approach, the IDT framework is compared against with three popular in-cremental methods, namely iCaRL, LwF and SupportNet. The experimental results on MNIST dataset achieved 87 % of accuracy and the obtained values on the BreakHis, the LBC and the SIPaKMeD datasets are promising with 92 %, 98 % and 93 % respectively.

This paper illustrates how a fuzzy logic approach can be used to formalize terms in the American College of Radiology (ACR) Breast Imaging Lexicon. In current practice, radiologists make a relatively subjective determination for many terms from the lexicon related to breast cancer diagnosis. Lobulation and microlobulation of nodules are two important features in the ACR lexicon. We offer an approach for formalizing the distinction of these features and also formalize the description of intermediate cases between lobulated and microlobulated masses. In this paper it is shown that fuzzy logic can be an effective tool in dealing with this kind of problem. The proposed formalization creates a basis for the next three steps: (i) extended verification with blinded comparison studies, (ii) the automatic extraction of the related primitives from the image, and (iii) the detection of lobulated and microlobulated masses based on these primitives. © 1997 Elsevier Science B.V.

Breast cancer is the most prevalent invasive type of cancer among women. The mortality rate of the disease can be reduced considerably through timely prognosis and felicitous treatment planning, by utilizing the computer aided detection and diagnosis techniques. With the advent of whole slide image (WSI) scanners for digitizing the histopathological tissue samples, there is a drastic increase in the availability of digital histopathological images. However, these samples are often unlabeled and hence they need labeling to be done through manual annotations by domain experts and experienced pathologists. But this annotation process required for acquiring high quality large labeled training set for nuclear atypia scoring is a tedious, expensive and time consuming job. Active learning techniques have achieved widespread acceptance in reducing this human effort in annotating the data samples. In this paper, we explore the possibilities of active learning on nuclear pleomorphism scoring over a non-Euclidean framework, the Riemannian manifold. Active learning technique adopted for the cancer grading is in the batch-mode framework, that adaptively identifies the apt batch size along with the batch of instances to be queried, following a submodular optimization framework. Samples for annotation are selected considering the diversity and redundancy between the pair of samples, based on the kernelized Riemannian distance measures such as log-Euclidean metrics and the two Bregman divergences - Stein and Jeffrey divergences. Results of the adaptive Batch Mode Active Learning on the Riemannian metric show a superior performance when compared with the state-of-the-art techniques for breast cancer nuclear pleomorphism scoring, as it makes use of the information from the unlabeled samples.

Breast Cancer is one of the most common causes of cancer death in women, representing a very complex disease with varied molecular alterations. To assist breast cancer prognosis, the classification of patients into biological groups is of great significance for treatment strategies. Recent studies have used an ensemble of multiple clustering algorithms to elucidate the most characteristic biological groups of breast cancer. However, the combination of various clustering methods resulted in a number of patients remaining unclustered. Therefore, a framework still needs to be developed which can assign as many unclustered (i.e. biologically diverse) patients to one of the identified groups in order to improve classification. Therefore, in this paper we develop a novel classification framework which introduces a new ensemble classification stage after the ensemble clustering stage to target the unclustered patients. Thus, a step-by-step pipeline is introduced which couples ensemble clustering with ensemble classification for the identification of core groups, data distribution in them and improvement in final classification results by targeting the unclustered data. The proposed pipeline is employed on a novel real world breast cancer dataset and subsequently its robustness and stability are examined by testing it on standard datasets. The results show that by using the presented framework, an improved classification is obtained. Finally, the results have been verified using statistical tests, visualisation techniques, cluster quality assessment and interpretation from clinical experts.

Breast and pectoral muscle segmentation is an essential pre-processing step for the subsequent processes in computer aided diagnosis (CAD) systems. Estimating the breast and pectoral boundaries is a difficult task especially in mammograms due to artifacts, homogeneity between the pectoral and breast regions, and low contrast along the skin-air boundary. In this paper, a breast boundary and pectoral muscle segmentation method in mammograms is proposed. For breast boundary estimation, we determine the initial breast boundary via thresholding and employ Active Contour Models without edges to search for the actual boundary. A post-processing technique is proposed to correct the overestimated boundary caused by artifacts. The pectoral muscle boundary is estimated using Canny edge detection and a pre-processing technique is proposed to remove noisy edges. Subsequently, we identify five edge features to find the edge that has the highest probability of being the initial pectoral contour and search for the actual boundary via contour growing. The segmentation results for the proposed method are compared with manual segmentations using 322, 208 and 100 mammograms from the Mammographic Image Analysis Society (MIAS), INBreast and Breast Cancer Digital Repository (BCDR) databases, respectively. Experimental results show that the breast boundary and pectoral muscle estimation methods achieved dice similarity coefficients of 98.8% and 97.8% (MIAS), 98.9% and 89.6% (INBreast) and 99.2% and 91.9% (BCDR), respectively.

The automatic diagnosis of breast cancer is an important, real-world medical problem. In this paper we focus on the Wisconsin breast cancer diagnosis (WBCD) problem, combining two methodologies-fuzzy systems and evolutionary algorithms-so as to automatically produce diagnostic systems. We find that our fuzzy-genetic approach produces systems exhibiting two prime characteristics: first, they attain high classification performance (the best shown to date), with the possibility of attributing a confidence measure to the output diagnosis; second, the resulting systems involve a few simple rules, and are therefore (human-) interpretable.

Objective: An integrated decision support framework is proposed for clinical oncologists making prognostic assessments of patients with operable breast cancer. The framework may be delivered over a web interface. It comprises a triangulation of prognostic modelling, visualisation of historical patient data and an explanatory facility to interpret risk group assignments using empirically derived Boolean rules expressed directly in clinical terms. Methods and materials: The prognostic inferences in the interface are validated in a multicentre longitudinal cohort study by modelling retrospective data from 917 patients recruited at Christie Hospital, Wilmslow between 1983 and 1989 and predicting for 931 patients recruited in the same centre during 1990-1993. There were also 291 patients recruited between 1984 and 1998 at the Clatterbridge Centre for Oncology and the Linda McCartney Centre, Liverpool, UK. Results and conclusions: There are three novel contributions relating this paper to breast cancer cases. First, the widely used Nottingham prognostic index (NPI) is enhanced with additional clinical features from which prognostic assessments can be made more specific for patients in need of adjuvant treatment. This is shown with a cross matching of the NPI and a new prognostic index which also provides a two-dimensional visualisation of the complete patient database by risk of negative outcome. Second, a principled rule-extraction method, orthogonal search rule extraction, generates readily interpretable explanations of risk group allocations derived from a partial logistic artificial neural network with automatic relevance determination (PLANN-ARD). Third, 95% confidence intervals for individual predictions of survival are obtained by Monte Carlo sampling from the PLANN-ARD model.

Objectives: The presence of microcalcifications (MCs), clusters of tiny calcium deposits that appear as small bright spots in a mammogram, has been considered as a very important indicator for breast cancer diagnosis. Much research has been performed for developing computer-aided systems for the accurate identification of MCs, however, the computer-based automatic detection of MCs has been shown difficult because of the complicated nature of surrounding of breast tissue, the variation of MCs in shape, orientation, brightness and size. Methods and materials: This paper presents a new approach for the effective detection of MCs by incorporating a knowledge-discovery mechanism in the genetic algorithm (GA). In the proposed approach, called knowledge-discovery incorporated genetic algorithm (KD-GA), the genetic algorithm is used to search for the bright spots in mammogram and a knowledge-discovery mechanism is integrated to improve the performance of the GA. The function of the knowledge-discovery mechanism includes evaluating the possibility of a bright spot being a true MC, and adaptively adjusting the associated fitness values. The adjustment of fitness is to indirectly guide the GA to extract the true MCs and eliminate the false MCs (FMCs) accordingly. Results and conclusions: The experimental results demonstrate that the incorporation of knowledge-discovery mechanism into the genetic algorithm is able to eliminate the FMCs and produce improved performance comparing with the conventional GA methods. Furthermore, the experimental results show that the proposed KD-GA method provides a promising and generic approach for the development of computer-aided diagnosis for breast cancer.

The prediction of clinical outcome of patients after breast cancer surgery plays an important role in medical tasks such as diagnosis and treatment planning. Different prognostic factors for breast cancer outcome appear to be significant predictors for overall survival, but probably form part of a bigger picture comprising many factors. Survival estimations are currently performed by clinicians using the statistical techniques of survival analysis. In this sense, artificial neural networks are shown to be a powerful tool for analysing datasets where there are complicated non-linear interactions between the input data and the information to be predicted. This paper presents a decision support tool for the prognosis of breast cancer relapse that combines a novel algorithm TDIDT (control of induction by sample division method, CIDIM), to select the most relevant prognostic factors for the accurate prognosis of breast cancer, with a system composed of different neural networks topologies that takes as input the selected variables in order for it to reach good correct classification probability. In addition, a new method for the estimate of Bayes' optimal error using the neural network paradigm is proposed. Clinical-pathological data were obtained from the Medical Oncology Service of the Hospital [email protected]?nico Universitario of Malaga, Spain. The results show that the proposed system is an useful tool to be used by clinicians to search through large datasets seeking subtle patterns in prognostic factors, and that may further assist the selection of appropriate adjuvant treatments for the individual patient.

In our previous work, we have presented an algorithm that extracts classification rules from trained neural networks and discussed its application to breast cancer diagnosis. In this paper, we describe how the accuracy of the networks and the accuracy of the rules extracted from them can be improved by a simple pre-processing of the data. Data pre-processing involves selecting the relevant input attributes and removing those samples with missing attribute values. The rules generated by our neural network rule extraction algorithm are more concise and accurate than those generated by other rule generating methods reported in the literature.